Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shigeharu Nakano
Dose Intensity/Body Surface Area Ratio Is a Novel Marker Useful for Predicting Response to Lenvatinib Against Hepatocellular Carcinoma
Cancers
Cancer Research
Oncology
Usefulness of Dose Intensity/Body Surface Area Ratio (DI/BSA Ratio; DBR) Rather Than Relative Dose Intensity in the Lenvatinib Treatment for Hepatocellular Carcinoma
Acta Hepatologica Japonica
Hepatology
Related publications
USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma
PLoS ONE
Multidisciplinary
SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
Lrig1 Is a Positive Prognostic Marker in Hepatocellular Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
SOX9 Is a Novel Cancer Stem Cell Marker Surrogated by Osteopontin in Human Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
Is Higher Dose Always the Right Answer in Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma?
Radiation Oncology Journal
Oncology
Radiology
Nuclear Medicine
Imaging
The Three Criteria for Radiological Response on Survival in Patients With Hepatocellular Carcinoma Treated With Lenvatinib
Hepatology Research
Hepatology
Infectious Diseases
Carnitine Insufficiency Is Associated With Fatigue During Lenvatinib Treatment in Patients With Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
